Sonnet BioTherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SONN and other ETFs, options, and stocks.About SONN
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.
CEORaghu Rao
CEORaghu Rao
Employees13
Employees13
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2011
Founded2011
Employees13
Employees13
SONN Key Statistics
Market cap12.28M
Market cap12.28M
Price-Earnings ratio-0.31
Price-Earnings ratio-0.31
Dividend yield—
Dividend yield—
Average volume13.65M
Average volume13.65M
High today$4.79
High today$4.79
Low today$3.10
Low today$3.10
Open price$3.65
Open price$3.65
Volume6.20M
Volume6.20M
52 Week high$10.02
52 Week high$10.02
52 Week low$1.08
52 Week low$1.08
People also own
Based on the portfolios of people who own SONN. This list is generated using Robinhood data, and it’s not a recommendation.